search
Back to results

PROphylactic Wound VACuum Therapy to Decrease Rates of Cesarean Section in the Obese Population (PROVAC)

Primary Purpose

Wound Complication

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Closed incision wound vacuum (Prevena)
Sponsored by
University of Pennsylvania
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Wound Complication focused on measuring obesity, cesarean section, wound complication

Eligibility Criteria

18 Years - 60 Years (Adult)FemaleAccepts Healthy Volunteers

Key inclusion criteria BMI greater than or equal to 30 kg/m2 at less than or equal to 22 weeks of gestation Subject is laboring Subject is having an unplanned cesarean section Subject will have Pfannenstiel Skin Incision Subject has the ability to take a picture and email it to a secure account Subject receives prenatal care in the University of Pennsylvania health system and plans to follow up postpartum in the system Subject is greater than or equal to 18 years of age

Key exclusion criteria Subject cannot read or speak English Subject is not 18 years of age Subject does not have ability to send a picture by email Subject has preexisting diabetes mellitus (Type 1 or Type 2) , is using chronic steroids or immune-suppressants, OR being actively treated for a malignancy Subject is undergoing a scheduled cesarean section Subject is allergic to silver

Sites / Locations

  • University of Pennsylvania

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Closed Incision Wound vacuum (Prevena)

Routine Wound Care

Arm Description

Closed incision wound vacuum (Prevena)

This arm includes patients having a cesarean section with routine wound care

Outcomes

Primary Outcome Measures

Number of Participants With Wound Complications
The primary outcome variable was a composite of wound morbidity at 4 weeks postpartum including SSI and/or wound opening

Secondary Outcome Measures

Pain Scores
On postoperative day 2, all patients were administered a pain scale: Rank sharp pain (0-10), 10 being worst possible sharp pain.
Tingling Pain Scores
On postoperative day 2, all patients were administered a pain scale: Rank tingling pain (0-10), 10 being worst possible tingling pain
Postpartum Length of Stay

Full Information

First Posted
April 29, 2014
Last Updated
September 12, 2017
Sponsor
University of Pennsylvania
Collaborators
Kinetic Concepts, Inc.
search

1. Study Identification

Unique Protocol Identification Number
NCT02128997
Brief Title
PROphylactic Wound VACuum Therapy to Decrease Rates of Cesarean Section in the Obese Population
Acronym
PROVAC
Official Title
Prophylactic Wound VACuum Therapy to Decrease Rates of Cesarean Section in the Obese Population
Study Type
Interventional

2. Study Status

Record Verification Date
September 2017
Overall Recruitment Status
Completed
Study Start Date
May 2014 (Actual)
Primary Completion Date
June 2016 (Actual)
Study Completion Date
August 2017 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Pennsylvania
Collaborators
Kinetic Concepts, Inc.

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
This study will assess whether a negative pressure wound vacuum therapy (NPWT) on closed incisions decreases the risk of wound complications among obese patients after cesarean section All patients having a cesarean section in labor or presenting to the triage unit and requiring a cesarean section will be eligible Main study intervention: this involves the use of a negative pressure wound vacuum therapy on a closed incision.
Detailed Description
Objectives To evaluate whether there is a decrease in wound complications among obese patients who are treated with closed incision NPWT versus standard post cesarean section wound care protocol. Primary outcome variable(s) The primary outcome variable is wound complications defined as any readmission for a wound issue within four weeks of discharge, infection, or wound breakdown. Secondary outcome will look at patient quality of life among those with NPWT versus usual care arm. A survey addressing pain, breast feeding questions and ability to perform activity of daily living will be administered during the inpatient stay and at the postpartum visit. Background Obesity, defined as a body mass index (BMI) 30kg/m2, continues to be a growing epidemic in the United States. According to National Center for Health Statistics Data1, almost one third of adults and 17% of youth were obese in 2009-2010. Furthermore, non-Hispanic Blacks have the age-adjusted rates of obesity (49.5%). In a study by Chu et al analyzing data from 26 states in the Pregnancy Risk Assessment Monitoring System (PRAMS) database, 20% of women who delivered were obese and in certain ethnic and insurance subgroups, the rates were as high as 33%. In 2008, according to reports by the Pennsylvania State statistics, the rates of obesity in the city of Philadelphia were as high as 64%. Multiple studies have demonstrated the increased risks for diabetes, hypertension and adverse pregnancy outcomes (APO) during pregnancy in the obese population. In addition, obesity is a well established independent risk factor for the development of a wound complication or infection after a cesarean delivery, with rates ranging from 10-15% . Certain measures such as antibiotic prophylaxis and closure of the subcutaneous space are techniques that have demonstrated a decreased incidence of wound disruption. Currently no randomized controlled trials have looked at the effects of surgical approach or choice of abdominal incision in the obese or extremely obese woman undergoing cesarean delivery. However, the few retrospective studies that have addressed this issue have demonstrated mixed results. Given the paucity of randomized controlled trials evaluating the prevention of wound complications in obese women undergoing cesarean delivery, a recent review by Tipton emphasized the necessity for such trials to evaluate methods with which to improve postoperative wound care and healing in this high risk cohort. In the past decade, negative pressure wound therapy (NPWT) has become accepted in the treatment of expediting healing of open wounds 15-18. NPWT is a method in which a vacuum device is placed on the wound in order to remove excess interstitial fluid, increase tissue vascularity, decrease bacterial colonization, and place mechanical stress on adjacent wound edges which aids in wound contractility and closure. Therefore, the positive effects of NPWT on open wounds have been well studied and established. Recent studies have been performed to assess a potential effect of NPWT on closed incisions non-obstetric fields. A recent study by Grauhan et al compared the effects of NPWT over closed sternotomy incisions in obese patients compared to conventional sterile wound dressing and noted a significant reduction in the rates of wound infection in those treated with NPWT. Another study by Vargo assessed the effects of NPWT on closed incisions in patients undergoing abdominal therapy compared to a historical control also noted a decreased wound infection rate and no evidence of skin necrosis. In contrast, a recent study by Masden et al. looked at rates of infection and dehiscence in patients with multiple comorbidities status post predominantly lower extremity wounds and did not appreciate a difference between the NPWT group and dry dressing group24. Therefore, the need for further studies assessing the benefits of NPWT on various anatomical sites has been clearly established.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Wound Complication
Keywords
obesity, cesarean section, wound complication

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
136 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Closed Incision Wound vacuum (Prevena)
Arm Type
Experimental
Arm Description
Closed incision wound vacuum (Prevena)
Arm Title
Routine Wound Care
Arm Type
No Intervention
Arm Description
This arm includes patients having a cesarean section with routine wound care
Intervention Type
Device
Intervention Name(s)
Closed incision wound vacuum (Prevena)
Intervention Description
wound vacuum to be placed on a closed incision
Primary Outcome Measure Information:
Title
Number of Participants With Wound Complications
Description
The primary outcome variable was a composite of wound morbidity at 4 weeks postpartum including SSI and/or wound opening
Time Frame
Four weeks after cesarean section
Secondary Outcome Measure Information:
Title
Pain Scores
Description
On postoperative day 2, all patients were administered a pain scale: Rank sharp pain (0-10), 10 being worst possible sharp pain.
Time Frame
Postpartum day 2
Title
Tingling Pain Scores
Description
On postoperative day 2, all patients were administered a pain scale: Rank tingling pain (0-10), 10 being worst possible tingling pain
Time Frame
Postpartum day 2
Title
Postpartum Length of Stay
Time Frame
Until hospital discharge and then for 4 weeks follow up

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Key inclusion criteria BMI greater than or equal to 30 kg/m2 at less than or equal to 22 weeks of gestation Subject is laboring Subject is having an unplanned cesarean section Subject will have Pfannenstiel Skin Incision Subject has the ability to take a picture and email it to a secure account Subject receives prenatal care in the University of Pennsylvania health system and plans to follow up postpartum in the system Subject is greater than or equal to 18 years of age Key exclusion criteria Subject cannot read or speak English Subject is not 18 years of age Subject does not have ability to send a picture by email Subject has preexisting diabetes mellitus (Type 1 or Type 2) , is using chronic steroids or immune-suppressants, OR being actively treated for a malignancy Subject is undergoing a scheduled cesarean section Subject is allergic to silver
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Celeste Durnwald, MD
Organizational Affiliation
University of Pennsylvania
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Pennsylvania
City
Philadelphia
State/Province
Pennsylvania
ZIP/Postal Code
19104
Country
United States

12. IPD Sharing Statement

Citations:
PubMed Identifier
28704847
Citation
Ruhstaller K, Downes KL, Chandrasekaran S, Srinivas S, Durnwald C. Prophylactic Wound Vacuum Therapy after Cesarean Section to Prevent Wound Complications in the Obese Population: A Randomized Controlled Trial (the ProVac Study). Am J Perinatol. 2017 Sep;34(11):1125-1130. doi: 10.1055/s-0037-1604161. Epub 2017 Jul 13.
Results Reference
derived

Learn more about this trial

PROphylactic Wound VACuum Therapy to Decrease Rates of Cesarean Section in the Obese Population

We'll reach out to this number within 24 hrs